The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for DP Rooker


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
 
Identification and biological activity of novel peptidomimetic gastrin/CCK-B receptor agonistsEBI
TBA
 
PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE)EBI
TBA
 
Novel cholecystokinin receptor ligands: Oxopiperazines derived from Boc-CCK-4EBI
TBA
New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists.EBI
Vantia
Non-peptide oxytocin agonists.EBI
Ferring Research
Peptidomimetic aminomethylene ketone inhibitors of interleukin-1 beta-converting enzyme (ICE).EBI
Ferring Research Institute
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.EBI
Ferring Research Institute
4-AMINO-3-(4-PHENOXYPHENYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE DERIVATIVES AND SALTS THEREOFBDB
Genzyme
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorBDB
Vertex Pharmaceuticals
Specialization among iron-sulfur cluster helicases to resolve G-quadruplex DNA structures that threaten genomic stability.BDB
National Institutes of Health, National Institutes of Health Biomedical Research Center
Synthesis and Biological Evaluation of 3-thiazolocoumarinyl Schiff-base Derivatives as Cholinesterase Inhibitors.BDB
Comsats Institute of Information Technology